netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

U.S. Blindness and Visual Impairment Will Double by 2050

A study supported by RPB and the National Eye Institute and conducted  by researchers at the University of Southern California (USC) Roski Eye Institute has found that the U.S. prevalence in visual impairment (VI) and blindness is expected to double over the next 35 years. By 2050, the number of Americans with a variety of eye disease and impairment issues, including age-related macular degeneration (AMD), glaucoma, diabetic retinopathy (DR) and cataracts, will dramatically increase impacting both individuals and society.

"Individuals who are visually impaired or blind have a higher risk of chronic health conditions, unintentional injuries, social withdrawal, depression, and mortality," write the investigators.

Read the story.

Read the report.

Related News: Top Story

RPB logo

Research to Prevent Blindness Announces New Sight-Saving Vision Research Grants

RPB launches awards in data science and Diabetic Eye Disease.

Read More

 
RPB Logo

Vision Research Funding Partnership Event Takes Place Today

Leaders of organizations that fund vision research convene in Washington DC to increase collaboration and maximize the impact of research funding for sight-threatening diseases.

Read More

 
Dr. Raj Apte

Understanding Corneal Injuries in Dry Eyes

An RPB grantee makes a key discovery involving genes that are essential for eye health.

Read More

 
RPB logo

Research to Prevent Blindness Marks $400 Million in Funding to Advance Eye Disease Research

RPB funds a new round of researchers and hits a milestone in supporting vision-related breakthroughs.

Read More

 
Giving Tuesday logo

RPB Supporters Save Sight on Giving Tuesday

We welcome your generosity to help us meet our goal!

Read More

 
Dr. Palczewski and lab members

An RPB Awardee Tackles Inherited Retinal Diseases

Dr. Krzysztof Palczewski develops and applies cutting-edge gene editing techniques to challenging genetic conditions.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.